Structural insights into competitive antagonism in NMDA receptors

Neuron

Volumn 81, Issue 2, 2014, Pages 366-378

  Jespersen, Annie ^a   Tajima, Nami ^a   Fernandez Cuervo, Gabriela ^b   Garnier Amblard, Ethel C ^b   Furukawa, Hiro ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUN1 PROTEIN; GLUN2A PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; COMPETITIVE INHIBITION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; LIGAND BINDING; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR BINDING; STRUCTURE ANALYSIS;

ANIMALS; BINDING SITES; CRYSTALLOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MICROINJECTIONS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUTATION; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 84892706964     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.11.033     Document Type: Article

References (57)

1. Acker T.M., Khatri A., Vance K.M., Slabber C., Bacsa J., Snyder J.P., Traynelis S.F., Liotta D.C. Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists. J. Med. Chem. 2013, 56:6434-6456.
2. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., Moriarty N.W., Read R.J., Sacchettini J.C., Sauter N.K., Terwilliger T.C. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 2002, 58:1948-1954.
3. Armstrong N., Gouaux E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 2000, 28:165-181.
4. Benveniste M., Mayer M.L. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys. J. 1991, 59:560-573.
5. Bettini E., Sava A., Griffante C., Carignani C., Buson A., Capelli A.M., Negri M., Andreetta F., Senar-Sancho S.A., Guiral L., Cardullo F. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J. Pharmacol. Exp. Ther. 2010, 335:636-644.
6. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
7. Clements J.D., Westbrook G.L. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 1991, 7:605-613.
8. Davies J., Watkins J.C. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res. 1982, 235:378-386.
9. Dawe G.B., Musgaard M., Andrews E.D., Daniels B.A., Aurousseau M.R., Biggin P.C., Bowie D. Defining the structural relationship between kainate-receptor deactivation and desensitization. Nat. Struct. Mol. Biol. 2013, 20:1054-1061.
10. Dyson H.J., Wright P.E., Scheraga H.A. The role of hydrophobic interactions in initiation and propagation of protein folding. Proc. Natl. Acad. Sci. USA 2006, 103:13057-13061.
11. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
12. Evans R.H., Francis A.A., Jones A.W., Smith D.A., Watkins J.C. The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br. J. Pharmacol. 1982, 75:65-75.
13. Farina A.N., Blain K.Y., Maruo T., Kwiatkowski W., Choe S., Nakagawa T. Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors. J. Neurosci. 2011, 31:3565-3579.
14. Feng B., Tse H.W., Skifter D.A., Morley R., Jane D.E., Monaghan D.T. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Br. J. Pharmacol. 2004, 141:508-516.
15. Frizelle P.A., Chen P.E., Wyllie D.J. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Mol. Pharmacol. 2006, 70:1022-1032.
16. Furukawa H., Gouaux E. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J. 2003, 22:2873-2885.
17. Furukawa H., Singh S.K., Mancusso R., Gouaux E. Subunit arrangement and function in NMDA receptors. Nature 2005, 438:185-192.
18. Gallagher M.J., Huang H., Pritchett D.B., Lynch D.R. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 1996, 271:9603-9611.
19. Hansen K.B., Ogden K.K., Traynelis S.F. Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J. Neurosci. 2012, 32:6197-6208.
20. Hayward S., Lee R.A. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. J. Mol. Graph. Model. 2002, 21:181-183.
21. Inanobe A., Furukawa H., Gouaux E. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron 2005, 47:71-84.
22. Irvine M.W., Costa B.M., Dlaboga D., Culley G.R., Hulse R., Scholefield C.L., Atlason P., Fang G., Eaves R., Morley R.M., et al. Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. J. Med. Chem. 2012, 55:327-341.
23. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325:529-531.
24. Kabsch W. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr. A 1976, 32:922-923.
25. Kandel E.R., Schwartz J.H., Jessel T.M. Essentials of Neural Science and Behavior 1995, Appleton & Lange, East Windsor.
26. Karakas E., Simorowski N., Furukawa H. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J. 2009, 28:3910-3920.
27. Karakas E., Simorowski N., Furukawa H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 2011, 475:249-253.
28. Kazi R., Gan Q., Talukder I., Markowitz M., Salussolia C.L., Wollmuth L.P. Asynchronous movements prior to pore opening in NMDA receptors. J. Neurosci. 2013, 33:12052-12066.
29. Mayer M.L. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron 2005, 45:539-552.
30. Mayer M.L. Emerging models of glutamate receptor ion channel structure and function. Structure 2011, 19:1370-1380.
31. Mayer M.L., Vyklicky L., Clements J. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 1989, 338:425-427.
32. Mayer M.L., Ghosal A., Dolman N.P., Jane D.E. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J. Neurosci. 2006, 26:2852-2861.
33. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Cryst. 2007, 40:658-674.
34. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
35. Mosley C.A., Acker T.M., Hansen K.B., Mullasseril P., Andersen K.T., Le P., Vellano K.M., Bräuner-Osborne H., Liotta D.C., Traynelis S.F. Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J. Med. Chem. 2010, 53:5476-5490.
36. Mullasseril P., Hansen K.B., Vance K.M., Ogden K.K., Yuan H., Kurtkaya N.L., Santangelo R., Orr A.G., Le P., Vellano K.M., et al. A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat. Commun. 2010, 1:90.
37. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276:307-326.
38. Pangborn A.B., Giardello M.A., Grubbs R.H., Rosen R.K., Timmers F. Safe and convenient procedure for solvent purification. Organometallics 1996, 15:1518-1520.
39. Paoletti P. Molecular basis of NMDA receptor functional diversity. Eur. J. Neurosci. 2011, 33:1351-1365.
40. Regalado M.P., Villarroel A., Lerma J. Intersubunit cooperativity in the NMDA receptor. Neuron 2001, 32:1085-1096.
41. Riou M., Stroebel D., Edwardson J.M., Paoletti P. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors. PLoS ONE 2012, 7:e35134.
42. Schauder D.M., Kuybeda O., Zhang J., Klymko K., Bartesaghi A., Borgnia M.J., Mayer M.L., Subramaniam S. Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc. Natl. Acad. Sci. USA 2013, 110:5921-5926.
43. Sobolevsky A.I., Rosconi M.P., Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009, 462:745-756.
44. Stern-Bach Y., Russo S., Neuman M., Rosenmund C. A point mutation in the glutamate binding site blocks desensitization of AMPA receptors. Neuron 1998, 21:907-918.
45. Still W.C., Khan M., Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 1978, 43:2923-2925.
46. Sun Y., Olson R., Horning M., Armstrong N., Mayer M., Gouaux E. Mechanism of glutamate receptor desensitization. Nature 2002, 417:245-253.
47. Talukder I., Wollmuth L.P. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening. J. Gen. Physiol. 2011, 138:179-194.
48. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010, 62:405-496.
49. Urwyler S., Campbell E., Fricker G., Jenner P., Lemaire M., McAllister K.H., Neijt H.C., Park C.K., Perkins M., Rudin M., et al. Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists-II. Pharmacological characterization in vivo. Neuropharmacology 1996, 35:655-669.
50. Vance K.M., Simorowski N., Traynelis S.F., Furukawa H. Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. Nat. Commun. 2011, 2:294.
51. Vicini S., Wang J.F., Li J.H., Zhu W.J., Wang Y.H., Luo J.H., Wolfe B.B., Grayson D.R. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J. Neurophysiol. 1998, 79:555-566.
52. Wallace A.C., Laskowski R.A., Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995, 8:127-134.
53. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 1981, 21:165-204.
54. Weston M.C., Schuck P., Ghosal A., Rosenmund C., Mayer M.L. Conformational restriction blocks glutamate receptor desensitization. Nat. Struct. Mol. Biol. 2006, 13:1120-1127.
55. Yao Y., Belcher J., Berger A.J., Mayer M.L., Lau A.Y. Conformational Analysis of NMDA Receptor GluN1, GluN2, and GluN3 Ligand-Binding Domains Reveals Subtype-Specific Characteristics. Structure 2013.
56. Yao Y., Harrison C.B., Freddolino P.L., Schulten K., Mayer M.L. Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors. EMBO J. 2008, 27:2158-2170.
57. Zauhar R.J., Colbert C.L., Morgan R.S., Welsh W.J. Evidence for a strong sulfur-aromatic interaction derived from crystallographic data. Biopolymers 2000, 53:233-248.